Mycophenolate mofetil treatment for primary glomerular diseases

Kidney International

Volumn 61, Issue 3, 2002, Pages 1098-1114

  Choi, Michael J ^a   Eustace, Joseph A ^a   Gimenez, Luis F ^a   Atta, Mohamed G ^a   Scheel, Paul J ^a   Sothinathan, Renuka ^a   Briggs, William A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Focal segmental glomerulosclerosis; Membranous nephropathy; Minimal change disease; Mycophenolate mofetil; Nephrotic syndrome; Renal insufficiency

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; SERUM ALBUMIN;

ADOLESCENT; ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MONOTHERAPY; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; TREATMENT OUTCOME;

EID: 0036186923     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00214.x     Document Type: Article

References (32)

1. Successful mycophenolate mofetil treatment of glomerular disease
2. Mycophenolate mofetil therapy in lupus nephritis: Clinical observations
3. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide
4. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
5. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney
6. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats
7. Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals
8. Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney
9. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney
10. Mycophenolate mofetil prevents the induction of active Heymann nephritis: Association with Th2 cytokine inhibition
11. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion
12. Mycophenolic acid: A new approach to the therapy of experimental mesangial proliferative glomerulonephritis
13. Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease
14. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus
15. Attenuation of murine lupus nephritis by mycophenolate mofetil
16. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy
17. Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil
18. Use of mycophenolate mofetil in resistant membranous nephropathy
19. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study of 11 patients with renal involvement
20. For the modification of diet in renal disease study group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
21. Lymphocyte selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: Role of deoxyguanosine nucleotide depletion
22. Mycophenolate mofetil (RS-61443): Mechanism of action and effects in transplantation
23. Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation
24. Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules
25. Brequinar sodium, mycophenolic acid, and cyclosporin A inhibit different stages of IL-4- or IL-13-induced human IgG 4 and IgE production in vitro
26. Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells
27. Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells
28. Mycophenolic acid increases apoptosis in lysosomes and lipid droplets in human lymphoid and monocytic cell lines
29. Primary focal segmental glomerulosclerosis: Clinical course and response to therapy
30. Evidence suggesting undertreatment in adults with idiopathic focal segmental glomerulosclerosis. Regional glomerulonephritis registry study
31. Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function
32. Mycophenolate mofetil in cadaveric renal transplantation